Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322 | ISIN: INE03Q201024 | Industry: Pharmaceuticals
| Expensive Underperformer
1015.0000 25.90 (2.62%)
NSE Apr 21, 2025 15:31 PM
Volume: 62,695
 

logo
Alivus Life Sciences Ltd.
29 Apr 2024
1015.00
2.62%
buy
by ICICI Direct
Target: 1040 | Target met
ICICI Direct
 
Number of FII/FPI investors increased from 92 to 105 in Mar 2025 qtr.
More from Alivus Life Sciences Ltd.
Recommended
Market closes higher, Jio Financial Services' net profit grows by 1.8% YoY to Rs 316.1 crore in Q4
Trendlyne Marketwatch | 21 Apr 2025, 04:26PM
IPOs This Week: Tankup Engineers' Issue Opens
| 21 Apr 2025, 04:01PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
| 27 Jul 2021